Hologic Company
Hologic engages in the development and supply of medical imaging systems and diagnostic products focused on the healthcare needs of women. The company operates in five segments: breast health (44% of sales), diagnostics (39%) surgical (14%), and skeletal health (3%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (74%), followed by Europe (12%), Asia (9%), and other international markets (5%). Hologic is headquartered in Bedford, Massachusetts.
Headquarters:
Marlborough, Massachusetts, United States
Last Funding Type:
Post-IPO Equity
Investors Number:
1
Last Funding Date:
2010-11-30
Acquisitions Number:
19
Employee Number:
10001+
Total Funding:
$450,000,000
Founded Date:
01-01-1985
Technology:
Biomarkers of Female Cancers
Estimated Revenue:
$500M to $1B
Industry:
General Health Care
Funding Status:
IPO